Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan†

PURPOSE: Abacavir is a nucleoside reverse transcriptase inhibitor indicated for human immunodeficiency virus (HIV) infection. In Japan, Ziagen® (300-mg abacavir sulfate) has been marketed since 1999. To obtain safety data on Ziagen, a mandatory postmarketing surveillance was conducted between Septem...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurita, Tomoko, Kitaichi, Tomomi, Nagao, Takako, Miura, Toshiyuki, Kitazono, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230480/
https://www.ncbi.nlm.nih.gov/pubmed/24585486
http://dx.doi.org/10.1002/pds.3589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230480/
https://www.ncbi.nlm.nih.gov/pubmed/24585486
http://dx.doi.org/10.1002/pds.3589

Ejemplares similares